✦ LIBER ✦

Pathologic Nonresponders after Neoadjuvant Chemoradiation for Esophageal Cancer Demonstrate no Survival Benefit Compared with Patients Treated with Primary Esophagectomy

✍ Scribed by George W. Dittrick; Jill M Weber; Ravi Shridhar; Sarah Hoffe; Marcovalerio Melis; Khaldoun Almhanna; James Barthel; James McLoughlin; Richard C. Karl; Kenneth L. Meredith

Book ID: 115031622
Publisher: Springer
Year: 2011
Tongue: English
Weight: 500 KB
Volume: 19
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-011-2078-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nomogram Score of Pathologic Complete Re

Nomogram Score of Pathologic Complete Response to Neoadjuvant Chemoradiation Predicts for Survival Outcomes in Esophageal Cancer Patients Treated With Definitive Chemoradiation

✍ Wang, J.; Lin, S.H.; Allen, P.K.; Juloori, A.; Lee, J.K.; Komaki, R.; Liao, Z.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Serum Vascular Endothelial Growth Factor

Serum Vascular Endothelial Growth Factor-A and Transforming Growth Factor-β1 Can Predict Pathological Response and Disease-Free Survival of Esophageal Cancer Patients Treated with Neoadjuvant Chemoradiation Therapy Followed by Esophagectomy

✍ Chiang, Y.; Cheng, J.; Graber, M.; Hsu, F.; Tsai, C.; Lee, J.; Chang, D.; Koong, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 72 KB